Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Fulcrum Therapeutics (FULC) Other Gross PP&E Adjustments (2019 - 2025)

Fulcrum Therapeutics (FULC) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $13.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 14.82% to $13.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.5 million, a 14.82% increase, with the full-year FY2025 number at $13.5 million, up 14.82% from a year prior.
  • Other Gross PP&E Adjustments was $13.5 million for Q4 2025 at Fulcrum Therapeutics, up from $13.4 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $14.6 million in Q4 2021 to a low of $5.3 million in Q1 2022.
  • A 5-year average of $11.0 million and a median of $11.2 million in 2024 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: tumbled 62.88% in 2022, then soared 61.5% in 2023.
  • Fulcrum Therapeutics' Other Gross PP&E Adjustments stood at $14.6 million in 2021, then tumbled by 45.56% to $8.0 million in 2022, then increased by 29.81% to $10.3 million in 2023, then increased by 13.97% to $11.8 million in 2024, then increased by 14.82% to $13.5 million in 2025.
  • Per Business Quant, the three most recent readings for FULC's Other Gross PP&E Adjustments are $13.5 million (Q4 2025), $13.4 million (Q3 2025), and $12.9 million (Q2 2025).